Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MITSUBISHI TANABE PHARMA CORPORATION et al v. MACLEODS PHARMACEUTICALS, LTD. et al
Case Number:
3:17-cv-13130
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
August 01, 2019
Janssen Gets Third Co. To Put Off Invokana Generic
Hetero Labs Ltd. has agreed to hold off on its generic version of Janssen's diabetes medication Invokana, putting an end to patent infringement litigation in New Jersey federal court.
-
December 15, 2017
Mitsubishi Says Generics Co.'s ANDA Infringes Diabetes Med
Mitsubishi Tanabe Pharma Corp. filed suit Friday in New Jersey federal court against India-based drugmaker Macleods Pharmaceuticals Ltd., alleging that the company had filed an abbreviated new drug application for a generic diabetes medication that would violate two of Mitsubishi's patents.